Physician profile
Noah P Thormeier
NPI 1790048528
$16,265.62
in general payments reported to CMS, 2019-2025
24 companies · $1,266 in 2025
The $1,266 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,557 · 2020: $1,781 · 2021: $795 · 2022: $1,668 · 2023: $2,546 · 2024: $3,652 · 2025: $1,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,810 · Consulting Fee: $3,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,809.63 |
| Consulting Fee | $3,655.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $7,631.61 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $2,994.26 | 2019-2025 | Watchman Access System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic Vascular, INC. | $1,870.73 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $939.03 | 2020 | |
| Medtronic, INC. | $734.06 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $666.14 | 2021-2025 | Amplatzer Amulet |
| Novartis Pharmaceuticals Corporation | $366.67 | 2019-2025 | |
| Biosense Webster, INC. | $218.51 | 2023-2025 | Nuvision Ice Catheter, Na |
| Abiomed | $208.51 | 2022-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $111.09 | 2019-2024 | Camzyos, Eliquis |
| Ge Healthcare | $91.82 | 2020 | |
| Shockwave Medical, INC | $73.21 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $54.88 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.60 | 2019-2025 | Jardiance |
| Amgen INC. | $39.10 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $36.85 | 2023 | Manta |
| Janssen Pharmaceuticals, INC | $35.65 | 2019 | |
| Biotronik INC. | $28.52 | 2020-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $28.47 | 2023 | Arcalyst |
| Cordis US Corp. | $19.51 | 2023 | Radial 360 |
| Novo Nordisk INC | $17.83 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $17.46 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.91 | 2019 | |
| Baylis Medical Company INC | $16.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Thormeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.